InsiderTrades

Form 4 for CELU Celularity Inc

Accepted 2025-04-15 00:00:00 ET · period of report 2025-04-13 · accession 0001641172-25-004822 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-04-15 2025-04-13 CELU Haines John R Senior Exec VP F - Tax $1.64 -577 29.1K -2% -$946.28
D 2025-04-15 2025-04-13 CELU Haines John R Senior Exec VP M - OptEx $0.00 +1,641 29.7K +6% $0
D 2025-04-15 2025-04-13 CELU Haines John R Senior Exec VP M - OptEx $0.00 -1,641 1,641 -50% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2025-04-13 F D 577 $1.64 29,121 D — —
2 Common Class A Common Stock 2025-04-13 M A 1,641 $0.00 29,698 D — — (F1) Represents the conversion upon vesting of restricted stock units (RSUs) into Class A common stock. On April 13, 2022, the reporting person was granted 6,562 RSUs, 25% of which vested on April 13, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on April 28, 2022.
3 Derivative Restricted Stock Units 2025-04-13 M D 1,641 $0.00 1,641 D — · — to — 1,641 Class A Common Stock (F3) Each restricted stock unit is the economic equivalent of one share of Celularity Inc. Class A Common Stock. (F4) On April 13, 2022, the reporting person was granted 6,562 RSUs, 25% of which vested on April 13, 2025. The Class a common stock into which such vested RSUs converted on April 13, 2025 is reported in Table I on this Form 4.